Aclaris Therapeutics (ACRS) Price to Sales (2017 - 2026)
Aclaris Therapeutics' (ACRS) Price to Sales was 90.00 for Q2 2026, up 882.2% from 9.16 a year earlier and up 43.8% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Price to Sales (2017 - 2026) Analysis & Trends
For FY2025, Price to Sales at Aclaris Therapeutics was 46.35, up 352.6% from FY2024.
- By year, Price to Sales came in at 10.24 in FY2024 (+329.9%), 2.38 in FY2023 (-93.3%), 35.30 in FY2022 (-73.2%) and 131.68 in FY2021 (+192.4%).
- The Q2 2026 figure ranks as the highest quarterly Price to Sales since Q2 2022.
- Year over year, Price to Sales has now increased in each of the last seven quarters, with growth averaging 360.4% over the last eight quarters.
- The high point for year-over-year Price to Sales in five years was Q2 2026 (growth of 882.2%); the low point was Q4 2023 (a decline of 93.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 62.59 (Q1 2026), 46.35 (Q4 2025) and 13.08 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Aclaris Therapeutics | 613.83 Mn | 613.83 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.00 |
| Mar 31, 2026 | 62.59 |
| Dec 31, 2025 | 46.35 |
| Sep 30, 2025 | 13.08 |
| Jun 30, 2025 | 9.16 |
| Mar 31, 2025 | 9.32 |
| Dec 31, 2024 | 10.24 |
| Sep 30, 2024 | 3.03 |
| Jun 30, 2024 | 2.45 |
| Mar 31, 2024 | 2.84 |
| Dec 31, 2023 | 2.38 |
| Sep 30, 2023 | 22.63 |
| Jun 30, 2023 | 23.55 |
| Mar 31, 2023 | 17.64 |
| Dec 31, 2022 | 35.30 |
| Sep 30, 2022 | 44.66 |
| Jun 30, 2022 | 151.55 |
| Mar 31, 2022 | 165.35 |
| Dec 31, 2021 | 131.68 |
| Sep 30, 2021 | 161.12 |
API Access
Aclaris Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();